A novel benzothiazine Ca 2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca 2+ currents

By Koidl B.   Miyawaki N.   Tritthart H.A.  

European Journal of Pharmacology, Vol. 322, Iss. 2, 1997-03 ,pp. : 243-247

Elsevier

Access to resources Recommend Favorite

Inhibition of recombinant human cardiac L-type Ca 2+ channel 1C subunits by 3-isobutyl-1-methylxanthine

By Fearon I.M.   Palmer A.C.V.   Balmforth A.J.   Ball S.G.   Mikala G.   Peers C.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 353-358

Elsevier

Access to resources Recommend Favorite

CP-060S interacts with three principal binding sites on the L-type Ca 2+ channel

By Suzuki Y.   Tamura K.   Adachi Y.   Fukazawa M.   Kato T.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 347-351

Elsevier

Access to resources Recommend Favorite

Effects of anandamide and arachidonic acid on specific binding of (+)-PN200-110, diltiazem and (-)-desmethoxyverapamil to L-type Ca 2+ channel

By Shimasue K.   Urushidani T.   Hagiwara M.   Nagao T.  

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 347-350

Elsevier

Access to resources Recommend Favorite

Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca 2+ channels

By Kanda S.   Adachi-Akahane S.   Nagao T.  

European Journal of Pharmacology, Vol. 358, Iss. 3, 1998-10 ,pp. : 277-287

Elsevier

Access to resources Recommend Favorite